• 대한영상의학회지
• /
• 제81권6호
• /
• pp.1486-1491
• /
• 2020

기쿠치병은 주로 아시아에 거주하는 젊은 여성에서 경부 림프절 비대와 열을 주소로 나타나는 조직구 괴사성 림프절염이며 자연적으로 치유되는 양성질환이다. 기쿠치병이 전형적으로 발현하는 위치가 아닌 림프절에서 발생하면 진단이 어려워지고 악성 질환으로 오인되기도 한다. 저자들은 2주간 지속되는 발열을 주소로 내원하여 시행한 초음파와 CT, 18F-fluorodeoxyglucose PET/CT에서 비장 종대와 경부, 액와부, 복강, 후복강, 서혜부 림프절 비대를 보여 림프종을 의심하였던 15세 여자 환아 증례를 보고한다. 복강 림프절 절제술로 기쿠치병을 진단하였다. 이후, 환자는 스테로이드로 보존적인 치료를 받고 발열 증상이 호전되어 퇴원하였다.

• 대한두경부종양학회:학술대회논문집
• /
• 대한두경부종양학회 2006년도 추계학술대회 논문집
• /
• pp.200-200
• /
• 2006

• 대한두경부종양학회:학술대회논문집
• /
• 대한두경부종양학회 2006년도 추계학술대회 논문집
• /
• pp.218-218
• /
• 2006

• Radiation Oncology Journal
• /
• 제30권4호
• /
• pp.173-181
• /
• 2012

Purpose: To evaluate the prognostic value of preoperative neck lymph node (LN) assessment with $^{18}F$-fluorodeoxyglucose positron emission tomography ($^{18}F$-FDG PET), computed tomography (CT), and magnetic resonance imaging (MRI) in oral cavity squamous cell carcinoma (OSCC) patients with pathologically positive LN. Materials and Methods: In total, 47 OSCC patients with pathologically positive LN were retrospectively reviewed with preoperative $^{18}F$-FDG PET and CT/MRI. All patients underwent surgical resection, neck dissection and postoperative adjuvant radiotherapy and/or chemotherapy between March 2002 and October 2010. Histologic correlation was performed for findings of $^{18}F$-FDG PET and CT/MRI. Results: Thirty-six (76.6%) of 47 cases were correctly diagnosed with neck LN metastasis by $^{18}F$-FDG PET and 32 (68.1%) of 47 cases were correctly diagnosed by CT/MRI. Follow-up ranged from 20 to 114 months (median, 56 months). Clinically negative nodal status evaluated by $^{18}F$-FDG PET or CT/MRI revealed a trend toward better clinical outcomes in terms of overall survival, disease-free survival, local recurrence-free survival, regional nodal recurrence-free survival, and distant metastasis-free survival rates even though the trends were not statistically significant. However, there was no impact of neck node standardized uptake value ($SUV_{max}$) on clinical outcomes. Notably, $SUV_{max}$ showed significant correlation with tumor size in LN (p < 0.01, $R^2$ = 0.62). PET and CT/MRI status of LN also had significant correlation with the size of intranodal tumor deposit (p < 0.05, $R^2$ = 0.37 and p < 0.01, $R^2$ = 0.48, respectively). Conclusion: $^{18}F$-FDG PET and CT/MRI at the neck LNs might improve risk stratification in OSCC patients with pathologically positive neck LN in this study, even without significant prognostic value of $SUV_{max}$.

• Nuclear Medicine and Molecular Imaging
• /
• 제40권5호
• /
• pp.271-274
• /
• 2006

We report the case of a 64-year-old man with superior vena cava (SVC) syndrome due to tumor thrombus from recurrent hepatocellular carcinoma (HCC). He presented with new onset of facial swelling for 10 days. HCC was detected ten years ago. He has undergone repeated transcatheter arterial embolization (TAE) and chemotherapy. Chest computed tomography (CT) demonstrated tumor thrombus in the SVC extending to right atrium. He underwent whole body F-18 fluorodeoxyglucose(FDG) positron emission tomography/computed tomography (PET/CT) scanning for assessing the effect of TAE in HCC. F-18 FDG PET/CT showed increased uptake in the residual liver mass indicating viable tumor. There was another intense F-18 FDG accumulation in SUV extending to right atrium to suggest tumor thrombus. This case illustrates that F-18 FDG PET/CT is useful to identification of distant metastases as well as assessment of response to therapy in long-term survival HCC patients.

• Nuclear Medicine and Molecular Imaging
• /
• 제43권5호
• /
• pp.499-504
• /
• 2009

F-18 fluorodeoxyglucose positron emission tomography (F-18 FDG PET/CT) plays an important role in diagnosis of malignant tumors and adds to conventional imaging in the staging of pertoneal carcinomatosis. However, false positive cases resulting from benign disease such as tuberculosis may occur. We report two cases of peritoneal tuberculosis on F-18 FDG PET/CT which showed multiple hypermetabolic foci in the mesentery and peritoneum with increased serum cancer antigen 125 (CA 125). Subsequent F-18 FDG PET/CT showed a disappearance of pathologic uptake following treatment with anti-tuberculosis drugs.

• Journal of Gastric Cancer
• /
• 제14권1호
• /
• pp.1-6
• /
• 2014

Aerobic glycolysis has been the most important hypothesis in cancer metabolism. It seems to be related to increased bioenergetic and biosynthetic needs in rapidly proliferating cancer cells. To this end, F-18 fluorodeoxyglucose (FDG), a glucose analog, became widely popular for the detection of malignancies combined with positron emission tomography/computed tomography (PET/CT). Although the potential roles of FDG PET/CT in primary tumor detection are not fully established, it seems to have a limited sensitivity in detecting early gastric cancer and mainly signet ring or non-solid types of advanced gastric cancer. In evaluating lymph node metastases, the location of lymph nodes and the degree of FDG uptake in primary tumors appear to be important factors affecting the diagnostic accuracy of PET/CT. In spite of the limited sensitivity, the high specificity of PET/CT for lymph node metastases may play an important role in changing the extent of lymphadenectomy or reducing futile laparotomies. For peritoneal metastases, PET/CT seems to have a poorer sensitivity but a better specificity than CT. The roles of PET/CT in the evaluation of other distant metastases are yet to be known. Studies including primary tumors with low FDG uptake or peritoneal recurrence seem suffer from poorer diagnostic performance for the detection of recurrent gastric cancer. There are only a few reports using FDG PET/CT to predict response to neoadjuvant or adjuvant chemotherapy. A complete metabolic response seems to be predictive of more favorable prognosis.

• 한국방사선학회논문지
• /
• 제7권5호
• /
• pp.365-369
• /
• 2013

PET(positron emission tomography)을 촬영하기 위해서는 방사선 의약품 동위원소를 사용하여 인체 내에 정맥주사를 한다. 이 경우 대표적으로 사용하는 방사선 의약품은 $^{18}FDG$ (Fluorodeoxyglucose)이다. 의료용 싸이크로트론으로 생산하는 $^{18}F$에 deoxyglucose를 합성하기 위해서 합성용 카세트장치가 필요하다. 방사성 의약품 제조시에는 많은 양의 2차 방사선이 발생이 된다. 따라서 2차 방사선을 차폐하기 위하여 핫셀(Hot cell)을 사용한다. 우리는 $^{18}FDG$ 합성 또는 분배시에 핫 셀 외부로 유출되는 선량을 측정하였다. 이번 실험은 $^{18}FDG$ 제조 작업시에 의도하지 않게 발생할 수 있는 방사선 작업종사자의 피폭에 관한 선량정보를 제공하기 위함이다. 결론적으로 핫셀 내부에서 외부로 $^{18}FDG$ 합성시에 선량이 유출됨을 확인 할 수 있었다. 특히 핫셀에서 핫셀 내부를 볼 수 있는 납유리에서 외부로 방사선이 유출되는 것을 알 수 있었다. 결론적으로 $^{18}FDG$ 합성시 방사선 작업종사자의 피폭선량을 감소하기 위해서는 핫셀 존재하는 납유리의 개선점이 필요할 것으로 사료된다.

• Korean Journal of Radiology
• /
• 제20권8호
• /
• pp.1293-1299
• /
• 2019

Objective: The purpose of this study was to evaluate the diagnostic performance of ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography (¹⁸F-FDG PET/CT) for chronic empyema-associated malignancy (CEAM). Materials and Methods: We retrospectively reviewed the ¹⁸F-FDG PET/CT images of 33 patients with chronic empyema, and analyzed the following findings: 1) shape of the empyema cavity, 2) presence of fistula, 3) maximum standardized uptake value (SUV) of the empyema cavity, 4) uptake pattern of the empyema cavity, 5) presence of a protruding soft tissue mass within the empyema cavity, and 6) involvement of adjacent structures. Final diagnosis was determined based on histopathology or clinical follow-up for at least 6 months. The abovementioned findings were compared between the ¹⁸F-FDG PET/CT images of CEAM and chronic empyema. A receiver operating characteristic (ROC) analysis was also performed. Results: Six lesions were histopathologically proven as malignant; there were three cases of diffuse large B-cell lymphoma, two of squamous cell carcinoma, and one of poorly differentiated carcinoma. Maximum SUV within the empyema cavity (p < 0.001) presence of a protruding soft tissue mass (p = 0.002), and involvement of the adjacent structures (p < 0.001) were significantly different between the CEAM and chronic empyema images. The maximum SUV exhibited the highest diagnostic performance, with the highest specificity (96.3%, 26/27), positive predictive value (85.7%, 6/7), and accuracy (97.0%, 32/33) among all criteria. On ROC analysis, the area under the curve of maximum SUV was 0.994. Conclusion: ¹⁸F-FDG PET/CT can be useful for diagnosing CEAM in patients with chronic empyema. The maximum SUV within the empyema cavity is the most accurate ¹⁸F-FDG PET/CT diagnostic criterion for CEAM.

• Nuclear Medicine and Molecular Imaging
• /
• 제43권6호
• /
• pp.582-587
• /
• 2009

A 59-year-old woman who was diagnosed with malignant pheochromocytoma underwent $^{18}F$-fluorodeoxyglucose positron emission tomography/computed tomography ($^{18}F$-FDG PET/CT). She had undergone left adrenalectomy for pheochromocytoma 4 years previously. Recent multiple metastatic pulmonary nodules were noted on the chest X-ray. After treatment with $^{131}I$-metaiodobenzylguanidine ($^{131}I$-MIBG) with 7.4 GBq, post-therapy $^{131}I$-MIBG scintigraphy depicted multiple distant metastases including lung, liver, abdominal para-aortic and mesenteric lymph nodes. $^{18}F$-FDG PET/CT also depicted multiple metastases in lung, liver, and abdominal para-aortic lymph nodes, but some lesions were not shown. In this case, $^{131}I$-MIBG scintigraphy found additional lesions in metastatic malignant pheochromocytoma.